Therefore, some people think that cancer immunotherapy should be combined with a strategy to increas the expression of CCL5 in tumors, thereby enhancing the infiltration of various immune cells into the TME, to increase the therapeutic effect [94]. This evidence concerns the gene CCL5 and cancer.